Search results for "RESPIRATORY SYSTEM"

showing 10 items of 1829 documents

DOES LEPTIN PLAY A CYTOKINE-LIKE ROLE WITHIN THE AIRWAYS OF COPD PATIENTS?

2005

The leptin-leptin receptor system might be up-regulated in the airways of chronic obstructive pulmonary disease (COPD). In bronchial biopsies obtained from normal subjects and smokers, with and without COPD, the present study examined leptin and leptin-receptor expression and their co-localisation in airway and inflammatory cells. Combining immunohistochemistry with terminal deoxynucleotidyl transferase dUTP nick end-labelling techniques, apoptosis in airway and inflammatory cells and in leptin and leptin-receptor expressing cells was investigated. In the epithelial cells both leptin and leptin-receptor expression was higher in normal subjects than in smokers and COPD subjects. By contrast,…

Pulmonary and Respiratory MedicineAdultLeptinMalemedicine.medical_specialtyCopd patientsmedicine.medical_treatmentT-LymphocytesApoptosisBronchiReceptors Cell SurfaceRespiratory MucosaPulmonary Disease Chronic ObstructiveInternal medicineBiopsyMedicineHumansAgedCOPDmedicine.diagnostic_testbusiness.industryLeptindigestive oral and skin physiologyRespiratory diseaseSmokingrespiratory systemMiddle Agedmedicine.diseaseObstructive lung diseaserespiratory tract diseasesRespiratory Function TestsEndocrinologyCytokineTerminal deoxynucleotidyl transferaseCase-Control StudiesImmunologyPhysical therapyReceptors LeptinFemalebusinesshormones hormone substitutes and hormone antagonistsCD8
researchProduct

Dexamethasone treatment for the acute respiratory distress syndrome: a multicentre, randomised controlled trial

2020

Background There is no proven specific pharmacological treatment for patients with the acute respiratory distress syndrome (ARDS). The efficacy of corticosteroids in ARDS remains controversial. We aimed to assess the effects of dexamethasone in ARDS, which might change pulmonary and systemic inflammation and result in a decrease in duration of mechanical ventilation and mortality. Methods We did a multicentre, randomised controlled trial in a network of 17 intensive care units (ICUs) in teaching hospitals across Spain in patients with established moderate-to-severe ARDS (defined by a ratio of partial pressure of arterial oxygen to the fraction of inspired oxygen of 200 mm Hg or less assesse…

Pulmonary and Respiratory MedicineAdultMaleARDSmedicine.medical_treatmentSeverity of Illness IndexDexamethasonelaw.invention03 medical and health sciences0302 clinical medicineRandomized controlled triallawFraction of inspired oxygenIntensive careSeverity of illnessmedicineData monitoring committeeHumans030212 general & internal medicineGlucocorticoidsDexamethasoneAgedMechanical ventilationRespiratory Distress Syndromebusiness.industryMiddle Agedmedicine.diseaseRespiration ArtificialIntensive Care UnitsTreatment Outcome030228 respiratory systemAnesthesiaAdministration IntravenousFemalebusinessmedicine.drug
researchProduct

Effect throughout the day of inhaled fenoterol on the bronchial responsiveness to histamine in asthmatic patients.

1987

The effect throughout the day of inhaled fenoterol on the bronchial responsiveness to inhaled histamine was evaluated in 8 asthmatic patients. The airway response to increasing concentration of histamine aerosol was assessed by measurement of forced expiratory volume in one second (FEV1). The provocative dose of histamine needed to cause a 20% fall in starting FEV1 was calculated from the cumulative log dose response curves. Histamine challenges were performed in duplicate, on separate days, after premedication with placebo or fenoterol given by metered dose inhalers in the morning and in the afternoon. The mean starting FEV1 in the morning and in the afternoon did not change significantly …

Pulmonary and Respiratory MedicineAdultMaleAdolescentmedicine.drug_classHistamine AntagonistsBronchial Provocation Testschemistry.chemical_compoundBronchodilatorForced Expiratory VolumemedicineHumansCircadian rhythmFenoterolAsthmaFenoterolbusiness.industryRespiratory diseaserespiratory systemmedicine.diseaseAsthmarespiratory tract diseasesCircadian RhythmBronchodilatationchemistryAnesthesiaImmunologyFemalebusinessAirwayHistaminemedicine.drugRespiration; international review of thoracic diseases
researchProduct

Soot-exposed mononuclear cells increase inflammatory cytokine mRNA expression and protein secretion in cocultured bronchial epithelial cells.

2000

<i>Background:</i> Soot particles are air pollutants capable of inducing airway and lung parenchymal injury. Mononuclear and bronchial epithelial cells are central to the maintenance of homeostasis and inflammation in the airways. <i>Objectives:</i> The aim of this study was to evaluate the contribution of mononuclear cells to the release of inflammatory mediators by bronchial epithelial cells. <i>Methods:</i> To model the in vivo situation, an in vitro system of cocultured blood monocytes and BEAS-2B cells was established in a transwell system. Blood monocytes were exposed to soot particles (FR 101) at concentrations of up to 100 μg/10<sup>6</su…

Pulmonary and Respiratory MedicineAdultMaleInflammationBronchiEnzyme-Linked Immunosorbent AssayBiologycomplex mixturesPeripheral blood mononuclear cellSensitivity and SpecificityMonocytesAir pollutantsParenchymamedicineHumansRNA MessengerSoot particlesCells CulturedAir PollutantsLungInterleukin-6Reverse Transcriptase Polymerase Chain ReactionInterleukin-8Epithelial CellsBlood Proteinsrespiratory systemCarbonCoculture Techniquesrespiratory tract diseasesCell biologymedicine.anatomical_structureSecretory proteinCytokinesCytokine mrnaFemalemedicine.symptomInflammation MediatorsRespiration; international review of thoracic diseases
researchProduct

Associations of diet and lifestyle factors with common volatile organic compounds in exhaled breath of average-risk individuals.

2018

Background Detection of diseases via exhaled breath remains an attractive idea despite persisting gaps in understanding the origin of volatile organic compounds (VOCs) and their relationship with the disease of interest. Data on factors potentially influencing the results of breath analysis remain rather sparse and often controversial. In this study, we aimed to investigate the associations of common VOCs in exhaled breath of average-risk individuals with socio-demographic and lifestyle factors, medical conditions as well as diet. Methods Alveolar breath samples of 1447 men and women were collected in the morning after fasting and were analyzed using gas-chromatography linked with mass-spec…

Pulmonary and Respiratory MedicineAdultMaleMultivariate analysisDietary factorsDisease01 natural sciences03 medical and health sciences0302 clinical medicineRisk FactorsEnvironmental healthMedicineHumansLife StyleAverage riskVolatile Organic Compoundsbusiness.industry010401 analytical chemistryExhalationMiddle Aged0104 chemical sciencesDietLifestyle factors030228 respiratory systemBreath gas analysisBreath TestsExhalationMultivariate AnalysisPopulation studyFemalebusinessJournal of breath research
researchProduct

THE EUROPEAN SLEEP APNOEA DATABASE (ESADA) -- Report from 22 European Sleep Laboratories

2011

The European Sleep Apnoea Database (ESADA) reflects a network of 22 sleep disorder centres in Europe enabled by a COST action B26 programme. This ongoing project aims to describe differences in standard clinical care of patients with obstructive sleep apnoea (OSA) and to establish a resource for genetic research in this disorder. Patients with suspected OSA are consecutively included and followed up according to local clinical standards. Anthropometrics, medical history, medication, daytime symptoms and sleep data (polysomnography or cardiorespiratory polygraphy) are recorded in a structured web-based report form. 5,103 patients (1,426 females, mean±SD age 51.8±12.6 yrs, 79.4% with apnoea/h…

Pulmonary and Respiratory MedicineAdultMalePediatricsmedicine.medical_specialtyAdolescentDatabases FactualCross-sectional studyPolysomnographyComorbidityCohort StudiesSleep Apnea SyndromesRisk FactorsSurveys and QuestionnairesmedicineHumansMedical historyRespiratory systemAgedSleep disordermedicine.diagnostic_testAnthropometryModels Geneticbusiness.industrycomorbidity European Sleep Apnoea Database genetic multicentre cohort obstructive sleep apnoea syndromeCardiorespiratory fitnessMED/11 - MALATTIE DELL'APPARATO CARDIOVASCOLAREAnthropometryMiddle Agedmedicine.diseaserespiratory tract diseasesObesity MorbidEuropeCohortFemaleHuman medicinebusiness
researchProduct

Fractional exhaled nitric oxide as a predictor of response to inhaled corticosteroids in patients with non-specific respiratory symptoms and insignif…

2017

Chronic non-specific respiratory symptoms are difficult to manage. This trial aimed to evaluate the association between baseline fractional exhaled nitric oxide (FeNO) and the response to inhaled corticosteroids in patients with non-specific respiratory symptoms.In this double-blind randomised placebo-controlled trial, we enrolled undiagnosed patients, aged 18-80 years, with cough, wheeze, or dyspnoea and less than 20% bronchodilator reversibility across 26 primary care centres and hospitals in the UK and Singapore. Patients were assessed for 2 weeks before being randomly assigned (1:1) to 4 weeks of treatment with extrafine inhaled corticosteroids (QVAR 80 μg, two puffs twice per day, equi…

Pulmonary and Respiratory MedicineAdultMalePediatricsmedicine.medical_specialtyAdolescentmedicine.drug_classPlaceboNitric Oxidelaw.invention03 medical and health sciencesYoung Adult0302 clinical medicineRandomized controlled trialDouble-Blind MethodlawBronchodilatorWheezeInternal medicineAdministration InhalationmedicineHumans030212 general & internal medicineAnti-Asthmatic AgentsRespiratory systemAdverse effectAgedAged 80 and overInhalationbusiness.industryBeclomethasoneMiddle Agedrespiratory systemRespiration Disordersrespiratory tract diseasesTreatment Outcome030228 respiratory systemExhalationExhaled nitric oxideFemaleHuman medicinemedicine.symptombusiness
researchProduct

Glutathione deficiency of the lower respiratory tract in patients with idiopathic pulmonary fibrosis.

2002

Idiopathic pulmonary fibrosis (IPF) is a disease of unknown aetiology. Increased oxidant burden and antioxidant, e.g. glutathione (GSH), deficiency in the lower respiratory tract have been thought to play a role in the progression of IPF. Sputum induction is a safe noninvasive tool to study inflammation in the respiratory tract. The aim of the present study was to evaluate the direct measurement of GSH in induced sputum supernatant. Sixteen IPF patients and 15 healthy, nonsmoking subjects underwent sputum induction. Total GSH in sputum, saliva and plasma was measured spectrophotometrically. Sputum GSH was decreased more then four-fold in IPF patients when compared to healthy subjects (mean …

Pulmonary and Respiratory MedicineAdultMalePulmonary FibrosisPathogenesischemistry.chemical_compoundIdiopathic pulmonary fibrosismedicineHumansSalivaLungAgedLungbusiness.industryRespiratory diseaseSputumGlutathionerespiratory systemMiddle Agedmedicine.diseaseGlutathionePathophysiologyrespiratory tract diseasesmedicine.anatomical_structurechemistryImmunologySputumFemalemedicine.symptombusinessRespiratory tractThe European respiratory journal
researchProduct

Effect of beclomethasone dipropionate on the bronchial responsiveness to propranolol in asthmatics.

1990

The effect of four weeks of treatment with beclomethasone dipropionate (BDP, 500 micrograms twice daily) on the bronchial responsiveness to propranolol was examined in 16 patients with mild asthma in a placebo-controlled, double-blind crossover study. Propranolol was inhaled in doubling concentrations and the results were expressed as the cumulative dose producing a 20 percent fall in FEV1 (PC20). After four weeks of treatment with BDP, the mean FEV1 increased from 82.0 percent predicted to 88.1 percent predicted. The difference was significant (p less than 0.001). Treatment with BDP did not significantly change the responsiveness to propranolol, the geometric mean PC20 being 3.17 mg/ml bef…

Pulmonary and Respiratory MedicineAdultMaleTime FactorsMild asthmaPropranololCritical Care and Intensive Care MedicineBronchial Provocation TestsRandom AllocationDouble-Blind MethodForced Expiratory VolumeAdministration InhalationmedicineAsthmatic patientHumansAsthmaBronchial SpasmCumulative dosebusiness.industryRespiratory diseaseBeclomethasonerespiratory systemmedicine.diseaseCrossover studyPropranololAsthmaAnesthesiaBronchoconstrictionFemalemedicine.symptomCardiology and Cardiovascular Medicinebusinessmedicine.drugChest
researchProduct

Oxidative lung injury correlates with one-lung ventilation time during pulmonary lobectomy: a study of exhaled breath condensate and blood.

2015

OBJECTIVES: During lung lobectomy, the operated lung is collapsed and hypoperfused; oxygen deprivation is accompanied by reactive hypoxic pulmonary vasoconstriction. After lung lobectomy, ischaemia present in the collapsed state is followed by expansion–reperfusion and lung injury attributed to the production of reactive oxygen species. The primary objective of this study was to investigate the time course of several markers of oxidative stress simultaneously in exhaled breath condensate and blood and to determine the relationship between oxidative stress and one-lung ventilation time in patients undergoing lung lobectomy. METHODS: This single-centre, observational, prospective study includ…

Pulmonary and Respiratory MedicineAdultMaleVentilator-Induced Lung InjuryIschemiaLung injuryDinoprostHypoxic pulmonary vasoconstrictionmedicineHumansExhaled breath condensateProspective StudiesLung cancerProspective cohort studyPneumonectomyNitritesAgedAged 80 and overLungNitratesbusiness.industryGeneral MedicineHydrogen Peroxiderespiratory systemMiddle Agedmedicine.diseaserespiratory tract diseasesOne-Lung VentilationOxidative Stressmedicine.anatomical_structureBreath TestsAnesthesiaReperfusion InjuryBreathingSurgeryFemaleCardiology and Cardiovascular MedicinebusinessBiomarkersEuropean journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery
researchProduct